Alliance Wealth Advisors LLC UT purchased a new stake in Synopsys, Inc. (NASDAQ:SNPS – Free Report) during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 2,557 shares of the semiconductor company’s stock, valued at approximately $1,262,000.
Several other hedge funds and other institutional investors also recently modified their holdings of SNPS. Vanguard Group Inc. grew its position in Synopsys by 20.7% in the 3rd quarter. Vanguard Group Inc. now owns 18,181,185 shares of the semiconductor company’s stock valued at $8,970,415,000 after buying an additional 3,120,401 shares during the last quarter. Norges Bank acquired a new stake in shares of Synopsys in the 2nd quarter worth $647,964,000. Ameriprise Financial Inc. boosted its holdings in shares of Synopsys by 29.1% in the second quarter. Ameriprise Financial Inc. now owns 2,598,874 shares of the semiconductor company’s stock valued at $1,333,095,000 after acquiring an additional 585,494 shares in the last quarter. M&G PLC increased its stake in shares of Synopsys by 86,263.0% during the third quarter. M&G PLC now owns 567,405 shares of the semiconductor company’s stock worth $279,731,000 after acquiring an additional 566,748 shares during the period. Finally, Massachusetts Financial Services Co. MA increased its stake in shares of Synopsys by 177.5% during the third quarter. Massachusetts Financial Services Co. MA now owns 865,987 shares of the semiconductor company’s stock worth $427,269,000 after acquiring an additional 553,924 shares during the period. 85.47% of the stock is currently owned by hedge funds and other institutional investors.
Analysts Set New Price Targets
A number of brokerages have weighed in on SNPS. KeyCorp lifted their price objective on Synopsys from $575.00 to $600.00 and gave the company an “overweight” rating in a report on Thursday, December 11th. Zacks Research upgraded Synopsys from a “strong sell” rating to a “hold” rating in a research note on Monday, November 10th. Bank of America raised Synopsys from an “underperform” rating to a “neutral” rating and dropped their price objective for the stock from $525.00 to $500.00 in a report on Monday, December 8th. HSBC cut Synopsys from a “buy” rating to a “hold” rating and set a $455.00 price objective for the company. in a research report on Friday. Finally, Citigroup began coverage on shares of Synopsys in a research report on Monday, November 24th. They set a “buy” rating and a $580.00 target price on the stock. Nine equities research analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, Synopsys currently has an average rating of “Hold” and a consensus target price of $547.00.
Synopsys Stock Performance
Shares of SNPS opened at $439.94 on Friday. Synopsys, Inc. has a 12-month low of $365.74 and a 12-month high of $651.73. The stock has a market cap of $84.17 billion, a P/E ratio of 55.06, a PEG ratio of 3.66 and a beta of 1.12. The company has a current ratio of 1.62, a quick ratio of 1.52 and a debt-to-equity ratio of 0.48. The company has a 50-day moving average of $474.06 and a two-hundred day moving average of $482.90.
Synopsys (NASDAQ:SNPS – Get Free Report) last issued its quarterly earnings data on Wednesday, December 10th. The semiconductor company reported $2.90 earnings per share for the quarter, topping analysts’ consensus estimates of $2.79 by $0.11. Synopsys had a net margin of 18.89% and a return on equity of 7.89%. The business had revenue of $2.25 billion during the quarter, compared to analysts’ expectations of $2.25 billion. During the same period last year, the company posted $3.40 EPS. The company’s revenue was up 37.8% on a year-over-year basis. Synopsys has set its FY 2026 guidance at 14.320-14.400 EPS and its Q1 2026 guidance at 3.520-3.580 EPS. As a group, research analysts predict that Synopsys, Inc. will post 10.64 EPS for the current fiscal year.
Insiders Place Their Bets
In other Synopsys news, insider Janet Lee sold 250 shares of the firm’s stock in a transaction dated Monday, January 12th. The shares were sold at an average price of $530.00, for a total transaction of $132,500.00. Following the sale, the insider directly owned 11,959 shares of the company’s stock, valued at $6,338,270. This trade represents a 2.05% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CFO Shelagh Glaser sold 3,657 shares of Synopsys stock in a transaction dated Friday, December 19th. The stock was sold at an average price of $460.77, for a total transaction of $1,685,035.89. Following the sale, the chief financial officer owned 17,842 shares of the company’s stock, valued at approximately $8,221,058.34. This trade represents a 17.01% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last ninety days, insiders have sold 4,157 shares of company stock worth $1,945,036. Corporate insiders own 0.62% of the company’s stock.
Key Synopsys News
Here are the key news stories impacting Synopsys this week:
- Positive Sentiment: NVIDIA added a large stake in Synopsys (reported ~4.8M shares, >$2.2B at end-Q4), highlighting strategic alignment between SNPS and AI/semiconductor leaders and lending a strong institutional vote of confidence. NVIDIA’s 13F Bombshell: A New AI Power Trio Emerges
- Positive Sentiment: Board refresh: Synopsys appointed former Deloitte executive Peter A. Shimer to the board and expanded the board as part of governance updates — adds deep financial and leadership experience that investors often view as supportive for oversight and capital allocation. Synopsys Appoints Former Deloitte Executive Peter Shimer to Board of Directors and Announces Board Transitions
- Positive Sentiment: Partnership expansion: Synopsys deepened its AI design and security capabilities via a SimuTech partnership, which could broaden product adoption in AI-focused chip design workflows. Synopsys Deepens AI Design And Security Reach With SimuTech Partnership
- Neutral Sentiment: Analysts and earnings watch: Multiple previews (Zacks/Yahoo) flag Q1 results as a near-term catalyst — key metrics vs. guidance will likely drive short-term volatility around the report. Synopsys (SNPS) Q1 Earnings on the Horizon: Analysts’ Insights on Key Performance Measures
- Neutral Sentiment: Mixed investor reaction coverage discusses AI-disruption fears, chiplet competition and the Ansys deal — narrative is mixed and could add noise to sentiment without a single clear directional effect. How Investors Are Reacting To Synopsys (SNPS) AI Disruption Fears Amid Chiplet Push And Ansys Deal
- Negative Sentiment: HSBC downgraded SNPS from Buy to Hold and set a $455 price target, a move that can weigh on sentiment and selling pressure even though the PT still implies modest upside. SNPS: HSBC downgrades
Synopsys Company Profile
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
See Also
- Five stocks we like better than Synopsys
- ~$1.5T SpaceX IPO: Pre-IPO Opportunity
- Gold $5,000: The 2026 Gold & Silver Summit is LIVE March 4
- How a Family Trust May Be Able To Help Preserve Your Wealth
- This makes me furious
- Elon Musk: This Could Turn $100 into $100,000
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
